BioCentury | Oct 5, 2015
Financial News

Apitope completes venture financing

...Autoimmune, Hematology, Ophthalmic Date completed: 2015-09-29 Type: Venture financing Raised: EUR12 million ($13.4 million) Investors: Wales Life Sciences Investment Fund...
BioCentury | Mar 31, 2014
Financial News

Verona Pharma completes placing and open offer

...£6.6 million ($10.8 million) in a placing; £6.4 million ($10.6 million) in a subscription to Wales Life Sciences Investment Fund...
BioCentury | Mar 10, 2014
Financial News

Verona Pharma proposes placing and open offer

...million ($11 million) in a placing; up to £6.4 ($10.7 million) in a subscription to Wales Life Sciences Investment Fund...
BioCentury | Jul 29, 2013
Finance

Alive and Welsh

...in a placing of 1 billion shares at 2.5p to new investors Abingworth; Invesco; and Wales Life Sciences Investment Fund...
...facility. As part of the financing, ReNeuron will receive £5 million ($7.6 million) from the Wales Life Sciences Investment Fund...
BioCentury | Jul 29, 2013
Financial News

ReNeuron proposes placing

...$38.7 million) Shares: 1 billion Price: 2.5p Shares outstanding prior: 774.8 million Investors: Abingworth; Invesco; Wales Life Sciences Investment Fund...
BioCentury | Jul 22, 2013
Financial News

ReNeuron to raise L25.4 million

...a placing of 1 billion shares at 2.5p to new investors Abingworth; Invesco; and the Wales Life Sciences Investment Fund...
...firm Arthurian Life Sciences, will join ReNeuron's board. Arthurian manages the L100 million ($152.6 million) Wales Life Sciences Investment Fund...
Items per page:
1 - 6 of 6
BioCentury | Oct 5, 2015
Financial News

Apitope completes venture financing

...Autoimmune, Hematology, Ophthalmic Date completed: 2015-09-29 Type: Venture financing Raised: EUR12 million ($13.4 million) Investors: Wales Life Sciences Investment Fund...
BioCentury | Mar 31, 2014
Financial News

Verona Pharma completes placing and open offer

...£6.6 million ($10.8 million) in a placing; £6.4 million ($10.6 million) in a subscription to Wales Life Sciences Investment Fund...
BioCentury | Mar 10, 2014
Financial News

Verona Pharma proposes placing and open offer

...million ($11 million) in a placing; up to £6.4 ($10.7 million) in a subscription to Wales Life Sciences Investment Fund...
BioCentury | Jul 29, 2013
Finance

Alive and Welsh

...in a placing of 1 billion shares at 2.5p to new investors Abingworth; Invesco; and Wales Life Sciences Investment Fund...
...facility. As part of the financing, ReNeuron will receive £5 million ($7.6 million) from the Wales Life Sciences Investment Fund...
BioCentury | Jul 29, 2013
Financial News

ReNeuron proposes placing

...$38.7 million) Shares: 1 billion Price: 2.5p Shares outstanding prior: 774.8 million Investors: Abingworth; Invesco; Wales Life Sciences Investment Fund...
BioCentury | Jul 22, 2013
Financial News

ReNeuron to raise L25.4 million

...a placing of 1 billion shares at 2.5p to new investors Abingworth; Invesco; and the Wales Life Sciences Investment Fund...
...firm Arthurian Life Sciences, will join ReNeuron's board. Arthurian manages the L100 million ($152.6 million) Wales Life Sciences Investment Fund...
Items per page:
1 - 6 of 6